Thus, we suspected that deficiency of KHSRP may suppress tumor progression and enhance the sensitivity of NSCLC cells to carboplatin by inhibiting EMT through downregulation of HMGB1 expression; whereas the precise underlying mechanisms require further investigation in future studies. This evidence concerns the gene KHSRP and non-small cell lung carcinoma.